- Home
- SBCF vs AZTA Comparison
SBCF vs AZTA Comparison
Compare SBCF & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- AZTA
- Stock Information
- Founded
- SBCF 1926
- AZTA 1978
- Country
- SBCF United States
- AZTA United States
- Employees
- SBCF N/A
- AZTA N/A
- Industry
- SBCF Major Banks
- AZTA Industrial Machinery/Components
- Sector
- SBCF Finance
- AZTA Technology
- Exchange
- SBCF Nasdaq
- AZTA Nasdaq
- Market Cap
- SBCF 2.5B
- AZTA 2.2B
- IPO Year
- SBCF N/A
- AZTA 1995
- Fundamental
- Price
- SBCF $29.50
- AZTA $41.51
- Analyst Decision
- SBCF Hold
- AZTA Buy
- Analyst Count
- SBCF 5
- AZTA 5
- Target Price
- SBCF $28.10
- AZTA $63.60
- AVG Volume (30 Days)
- SBCF 433.8K
- AZTA 533.4K
- Earning Date
- SBCF 10-24-2024
- AZTA 11-12-2024
- Dividend Yield
- SBCF 2.44%
- AZTA N/A
- EPS Growth
- SBCF 10.93
- AZTA N/A
- EPS
- SBCF 1.36
- AZTA N/A
- Revenue
- SBCF $494,135,000.00
- AZTA $656,323,000.00
- Revenue This Year
- SBCF N/A
- AZTA $0.52
- Revenue Next Year
- SBCF $8.42
- AZTA $6.49
- P/E Ratio
- SBCF $21.70
- AZTA N/A
- Revenue Growth
- SBCF N/A
- AZTA N/A
- 52 Week Low
- SBCF $21.23
- AZTA $40.24
- 52 Week High
- SBCF $30.78
- AZTA $69.16
- Technical
- Relative Strength Index (RSI)
- SBCF 60.06
- AZTA 38.58
- Support Level
- SBCF $29.09
- AZTA $44.72
- Resistance Level
- SBCF $30.71
- AZTA $50.81
- Average True Range (ATR)
- SBCF 0.85
- AZTA 2.24
- MACD
- SBCF 0.18
- AZTA 0.04
- Stochastic Oscillator
- SBCF 72.05
- AZTA 5.78
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.